DRUGtrain ITN

DRUGtrain project is funded by the European Union's Horizon 2020 under the Marie Skłodowska-Curie grant agreement No 955879

[DRUGtrain ITN @DrugTrain_ITN]

Publication alert from DRUGtrain ITN 🚨

"Targeting Kidney Fibrosis with Polymeric Nanocarriers" By ESR Vedangi Kulkarni (@k_vedangi) and Prof. Dr. Twan Lammers (@twan_lammers) et al. from Uniklinik RWTH Aachen.@UniklinikAachen.

https://t.co/UILJTPHr2x

[Bola Khalil @BolaK_DDD]

I’m grateful to have been awarded the Best Poster at EuroQSAR 2024 🎉🏆 for our work on Uncertainty Quantification in Bioactivity Assessment.

[DRUGtrain ITN @DrugTrain_ITN]

The study demonstrates how physicochemical modifications of p(HPMA) enhance targeted delivery to diseased kidneys, towards improving the efficiency of kidney fibrosis treatments.

[DRUGtrain ITN @DrugTrain_ITN]

Publication alert from DRUGtrain ITN 🚨

"Targeting Kidney Fibrosis with Polymeric Nanocarriers" By ESR Vedangi Kulkarni (@k_vedangi) and Prof. Dr. Twan Lammers (@twan_lammers) et al. from Uniklinik RWTH Aachen.@UniklinikAachen.

https://t.co/UILJTPHr2x

[DRUGtrain ITN @DrugTrain_ITN]

What an exceptional 5th DRUGtrain consortium meeting! It was inspiring to witness how each individual project contributes to our collective mission of utilizing drug repurposing for the treatment of ADPKD. Lots of thanks to the University of Konstanz for hosting!
#ADPKD #MSCA

[DRUGtrain ITN @DrugTrain_ITN]

ESR Vedangi Kulkarni presented her work at @CRSScience Expo 2023. Congratulations to her for winning the award 👏👏

[DRUGtrain ITN @DrugTrain_ITN]

Check out ESR @ShannonAJenkins at #WCP2023 today! She'll be sharing new ideas in high throughput screening platforms for #ADPKD drug screening

[Shannon Amy Jenkins @ShannonAJenkins]

Good morning #WCP2023! Pop by to poster 674 to see my work so far on the development of a phenotypic model of #ADPKD for high-throughput screening as part of the @DrugTrain_ITN

#HTS #DrugDiscovery

[DRUGtrain ITN @DrugTrain_ITN]

Countdown #ScienceIsWonderful in Brussels on 16-17 March 2023! ESRs @ShannonAJenkins and @_Alina_Meyer will be sharing our research on drug repurposing for treatment of ADPKD with pupils from Belgium and beyond. Visit out stand. For registrations https://t.co/yrddK8wYA4

[DRUGtrain ITN @DrugTrain_ITN]

Don't forget to drop by Booth 12 at #ScienceIsWonderful in Brussels. @_Alina_Meyer and @ShannonAJenkins

[Shannon Amy Jenkins @ShannonAJenkins]

Counting down the days to #ScienceIsWonderful! 16th and 17th March @_Alina_Meyer and I will be at booth 12, where we'll introduce pupils in Brussels and beyond to drug repurposing. Maybe we'll inspire some future "drug discovery detectives"! 😄
@DrugTrain_ITN

[Twan Lammers @twan_lammers]

Postdoc, PhD and Technician positions available @UniklinikAachen and @RWTH. Join our diverse and dynamic team to work on translational aspects of cancer nanomedicine and nano-immunotherapy. Projects funded by @dfg_public and @ERC_Research. Contact via email or DM. Pls retweet 🙏

[DRUGtrain ITN @DrugTrain_ITN]

Countdown #ScienceIsWonderful in Brussels on 16-17 March 2023! ESRs @ShannonAJenkins and @_Alina_Meyer will be sharing our research on drug repurposing for treatment of ADPKD with pupils from Belgium and beyond. Visit out stand. For registrations https://t.co/yrddK8wYA4

[DRUGtrain ITN @DrugTrain_ITN]

Great opportunity for aspiring PhD candidates

[Madlen Hubert @HubertMadlen]

🚨#jobalert🚨
We look for an enthusiastic #PhD student with an interest in #RNA therapies to join @GENEGUT_EU! Help us develop 3D intestinal #organoid cultures to understand intracellular delivery of novel RNA-#nanoparticles. Please RT!

Apply now👇
https://t.co/RdOMPuhNvU

[Farmaceutiska fakulteten @FFakulteten]

Meet @_Alina_Meyer, PhD student at @UU_University, who within the European @DrugTrain_ITN consortium is exploring #drug #repurposing to find a treatment for the currently incurable kidney disease #ADPKD 👉 https://t.co/NpeBdPzUU2

[DRUGtrain ITN @DrugTrain_ITN]

DRUGtrain blogpost covering consortium meeting in Leiden, the Netherlands is now online!
@GlobalLumc @UniLeiden
#drugrepurposing
https://t.co/jae4r8wsWc

[Twan Lammers @twan_lammers]

👇 Timely, comprehensive and complete review in @NatRevNeph on imaging tools and technologies for monitoring chronic kidney disease. Note that CKD will be one the major disease challenges for the 21st century… @DrugTrain_ITN @LaBOORatory @rkramann @ESMI_SG_IGDD #RTG2375 #KFO5011

[Shannon Amy Jenkins @ShannonAJenkins]

Yesterday brought to an end the 3rd @DrugTrain_ITN consortium meeting in Aachen @RWTH where we attended a fantastic training course and had the opportunity to present our research to-date. Thanks to @twan_lammers and @k_vedangi for hosting such a great event! #DRUGtrain #ITN

[Twan Lammers @twan_lammers]

Inspiring and entertaining @DrugTrain_ITN Marie Curie Innovative Training Network meeting on Drug Repurposing 🧑‍🔬 at @RWTH Aachen. Elevator pitches by our ESR's were brilliant. Congrats @k_vedangi for winning the pitch award🏆. Thanks Babs for excellent project management🙏

[Twan Lammers @twan_lammers]

Grateful and happy to be part of the DRUGtrain Marie Curie Training Network focusing on Drug Repurposing 💊. Looking forward to hosting the next consortium and training meeting at CBMS in Aachen on October 18-19. @DrugTrain_ITN @k_vedangi

[DRUGtrain ITN @DrugTrain_ITN]

Meet our own Early-Stage Researchers David Araripe (ESR-1) @DavidAraripe and Bola Khalil (ESR-4) @BolaK_DDD presenting their #computational #chemistry work at the 12th International Conference on Chemical Structures #2022ICCS

[DRUGtrain ITN @DrugTrain_ITN]

8 beneficiaries across EU will join forces to train a next generation of multi-disciplinary researchers in biomedical and (bio)pharmaceutical sciences, offering a timely paradigm to improve drug repurposing with a focus on ADPKD. Follow us here: https://t.co/BW2mopFew3